Effect of the Coronavirus Disease 2019 Pandemic on Retinal Artery Occlusion

Tetsuya Muto1,2,3, Shigeki Machida2, Shinichiro Imaizumi1

  • 1Department of Ophthalmology, Imaizumi Eye Hospital, Koriyama, Japan.

Insights

The COVID-19 pandemic did not change the prevalence of retinal artery occlusion (RAO) in Japan. However, final visual acuity worsened for branch RAO (BRAO) patients after the emergency declaration.

Area of Science:

  • Ophthalmology
  • Public Health
  • Epidemiology

Background:

  • Retinal artery occlusion (RAO) is a serious condition affecting vision.
  • The COVID-19 pandemic led to significant societal changes, potentially impacting healthcare access and patient outcomes.
  • Understanding the pandemic's effect on RAO prevalence and characteristics is crucial for ophthalmological practice.

Purpose of the Study:

  • To assess the prevalence and clinical features of branch RAO (BRAO) and central RAO (CRAO) in new patients before and after Japan's COVID-19 state of emergency declaration.
  • To compare demographic data, prevalence rates, and visual acuity outcomes between pre- and post-emergency periods.

Main Methods:

  • Retrospective cohort study comparing RAO patients diagnosed before (April 7, 2020) and after the state of emergency declaration.
  • Analysis included prevalence, sex ratio, age, and initial/final best-corrected visual acuity (BCVA).
  • Rates of rhegmatogenous retinal detachment (RRD) and pseudoexfoliation glaucoma (PEX) were also compared.

Main Results:

  • No significant differences in RAO, RRD, or PEX prevalence, sex ratio, or age were observed between the 'Before' and 'After' groups.
  • Initial BCVA for RAO patients showed no significant change.
  • Final BCVA significantly worsened in the 'After' group for BRAO patients (p=0.002).

Conclusions:

  • The COVID-19 pandemic did not alter the prevalence of RAO, RRD, or PEX among new patients.
  • Despite stable prevalence, the pandemic may have influenced the pathophysiology or management of RAO, leading to poorer visual outcomes in BRAO.
  • Further research is needed to elucidate the mechanisms behind the observed decline in final visual acuity for BRAO patients during the pandemic.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...